Ischemic preconditioning reduces caspase-related intestinal apoptosis

Surgery Today

Volumn 35, Issue 3, 2005, Pages 228-234

  Aban, Nedim ^a,c   Cinel, Leyla ^b   Tamer, Lulufer ^b   Aktas, Atil ^b   Aban, Meral ^b  

^a Mersin SSK Hospital   (Turkey)

^b MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c Fatih Mah   (Turkey)

Author keywords

Apoptosis; Caspase; Intestine; Ischemia reperfusion; Ischemic preconditioning

Indexed keywords

CASPASE; CASPASE 3; MYELOPEROXIDASE; NITRATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY WEIGHT; CELL COUNT; CONTROLLED STUDY; ENZYME BLOOD LEVEL; EVALUATION; HEART; HISTOPATHOLOGY; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE INJURY; INTESTINE ISCHEMIA; LAPAROTOMY; MALE; MEASUREMENT; NONHUMAN; PROPHYLAXIS; PROTEIN EXPRESSION; PUNCTURE; RANDOMIZATION; RAT; REPERFUSION; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; TIME;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CASPASE 3; CASPASES; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INTESTINE, SMALL; ISCHEMIA; ISCHEMIC PRECONDITIONING; LAPAROTOMY; MALE; PEROXIDASE; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; REPERFUSION INJURY; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 17044378210     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-004-2918-y     Document Type: Article

References (39)

1. Papathanassoglou ED, Moynihan J, Ackerman MH. Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical framework. Crit Care Med 2000;28:537-49.
2. Noda T, Iwakiri R, Fujimoto K, Matsuo S, Aw TY. Programmed cell death induced by I/R in rat intestinal mucosa. Am J Physiol 1998;274:270-6.
3. Husain KD, Coopersmith CM. Role of intestinal epithelial apoptosis in survival. Curr Opin Crit Care 2003;9:159-63.
4. Komatsu H, Koo A, Ghadishah E, Zeng H, Kuhlenkamp JF, Inave M, et al. Neutrophil accumulation in ischemic reperfused rat liver: evidence for a role for superoxide free radicals. Am J Physiol 1992;262:G669-76.
5. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000;190:255-66.
6. Hotchkiss RS, Schmieg RE Jr, Swanson PE, Freeman BD, Tinsley KW, Cobb JP et al. Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock. Crit Care Med 2000;28:3207-17.
7. Buttke JM, Sandrtrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994;15:7-10.
8. McCallion K, Wattanasirichaigoon S, Gardiner KR, Fink MP. Ischemic preconditioning ameliorates ischemia- and reperfusion-induced hyperpermeability in rats. Shock 2000;14:429-34.
9. Aksoyek S, Cinel I, Avlan D, Cinel L, Ozturk C, Gurbuz P, et al. Intestinal ischemic preconditioning protects the intestine and reduces bacterial translocation. Shock 2002,18;476-80.
10. Maulik N, Engelman RM, Rousou JA, Flack JE 3rd, Deaton D, Das DK. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation 1999;100 (19 suppl):II 369-75.
11. Cinel I, Avlan D, Cinel L, Polat G, Atici S, Mavioglu I, et al. Ischemic preconditioning reduces intestinal epithelial apoptosis in rats. Shock 2003;19:588-92.
12. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-5.
13. Golowich SP, Kaplan SD. Methods in enzymology. Vol. II. New York: Academic Press; 1955. p. 769.
14. Chiu CJ, McArdle AH, Brown R, Scott H, Gurd F. Intestinal mucosal lesion in low flow states. Arch Surg 1970;101:478-83.
15. Gullo A, Berlot G. Ingredients of organ dysfunction or failure. World J Surg 1996;20:430-6.
16. Kubes P. Polymorphonuclear leucocyte-endothelium interactions: a role for pro-inflammatory and anti-inflammatory molecules. Can J Physiol Pharmacol 1993;71:88-92.
17. Rosales C, Juliano RL. Signal transduction by cell adhesion receptors in leucocytes. J Leucocyte Biol 1995;57:189-94.
18. Cuzzocrea S, Mazzon E, Costantino G, Serraino I, De Sarro A, Caputi AP. Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovasc Res 2000;47:537-48.
19. Ozdulger A, Cinel I, Koksel O, Cinel L, Avlan D, Unlu A, et al. The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock 2003;19:366-72.
20. Potoka AD, Nadler EP, Upperman JS, Ford HR. Role of nitric oxide and peroxynitrite in gut barrier failure. World J Surg 2002; 26:806-11.
21. Nadler EP, Ford HR. Regulation of bacterial translocation by nitric oxide. Pediatr Sury Int 2000;16:165-8.
22. Clementi E, Brown GC, Feelisch M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 1998;95:7631-6.
23. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
24. Hortelano S, Dallaporta B, Zamzami N, Hirsch T, Susin SA, Marzo I, et al. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition. FEBS Lett 1997;410:373-7.
25. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424-37.
26. Cinel I, Oral U. Nitric oxide synthase, poly(ADP-Ribose) synthetase and ischemic preconditioning. Crit Care Med 2002;30:2167-8.
27. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-51.
28. Coopersmith CM, O'Donnell D, Gordon JI. Bcl-2 inhibits I/R induced apoptosis in the intestinal epithelium of transgenic mice. Am J Physiol 1999;276:677-86.
29. Zhao H, Yenari MA, Cheng D, Sapolsky RM, Steinberg GK. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem 2003;85:1026-36.
30. Zhao ZQ, Morris CD, Budde JM, Wang NP, Muraki S, Sun HY, et al. Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion. Cardiovasc Res 2003 1;59:132-42.
31. Zingarelli B, Hake PW, O'Connor M, Denenberg A, Kong S, Aronow BJ. Absence of poly(ADP-ribose)polymerase-1 alters nuclear factor-kappa B activation and gene expression of apoptosis regulators afer reperfusion injury. Mol Med 2003;9:143-53.
32. Maulik N, Goswami S, Galang N, Das DK. Differential regulation of Bcl-2, AP-1, and NF-kappa B on cardiomyocyte apoptosis during myocardial ischemic stress response. FEBS Lett 1999;443:331-6.
33. Yeh KY, Yeh M, Glass J, Granger DN. Rapid activation of NF-kB and AP-1 and target gene expresssion in postischemic rat intestine. Gastroenterology 2000;118:525-34.
34. Szabo C. Role of poly(ADP-ribose) synthetase in inflammation. Eur J Pharmacol 1998;350:1-19.
35. Jagtap P, Soriano FG, Virag L, Liaudet L, Mabley J, Szabo E, et al. Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit Care Med 2002;30:1071-82.
36. Cuzzocrea S, Mazzon E, De Sarro A, Caputi AP. Role of free radicals and poly (ADP-ribose) synthetase in intestinal tight junction permeability. Mol Med 2000;6:766-78.
37. Liaudet L, Szabo A, Soriano FG, Zingarelli B, Szabo C, Salzman AL. Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock 2000;14:142-3.
38. Liaudet L, Yang Z, Al-Affar EB, Szabo C. Myocardial ischemic preconditioning in rodents is dependent on poly (ADP-ribose) synthetase. Mol Med 2001;7:406-17.
39. Davis JM, Gute DC, Jones S, Krsmanovic A, Korthuis RJ. Ischemic preconditioning prevents postischemic p-selectin expression in the rat small intestine. Am J Physiol 1999;277:H2476-81.